APA (7th ed.) Citation

M, A., F, D. B., B, V., L, T., M, B., P, B., . . . G, M. (2026). Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: The multicentre retrospective CEFI-BAC study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 163, 108305. https://doi.org/10.1016/j.ijid.2025.108305

Chicago Style (17th ed.) Citation

M, Augello, et al. "Real-world Use of Cefiderocol as Monotherapy or Combination Therapy for the Treatment of Gram-negative Bacterial Infections: The Multicentre Retrospective CEFI-BAC Study." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases 163 (2026): 108305. https://doi.org/10.1016/j.ijid.2025.108305.

MLA (9th ed.) Citation

M, Augello, et al. "Real-world Use of Cefiderocol as Monotherapy or Combination Therapy for the Treatment of Gram-negative Bacterial Infections: The Multicentre Retrospective CEFI-BAC Study." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, vol. 163, 2026, p. 108305, https://doi.org/10.1016/j.ijid.2025.108305.